Switch to Dark

Pricing

Learn

LLY - Eli Lilly and Co

496

$917.50

-$0.55 (-0.060%)

At market close

$918.01

$0.50 (0.055%)

After Hours 3/19/26, 10:00 PM

Score

4.55/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Income Statement Summary

Metrics

KPIs

View as %

Eli Lilly and Co

Stock Unlock

Legend	CAGR	Total Change	Average	Median	Low	High	Latest
Total Revenue	73.66%	51.57%	$16.29B	$16.58B	$12.73B 2025-03-31	$19.29B 2025-12-31	$19.29B 2025-12-31

Operating Expenses	46.42%	33.28%	$6.11B	$6.15B	$5.20B 2025-03-31	$6.93B 2025-12-31	$6.93B 2025-12-31

Net Interest Income Expense	--	64.05%	-$156.95M	-$109.00M	-$342.10M 2025-03-31	-$67.70M 2025-09-30	-$123.00M 2025-12-31

Income Tax Expense	209%	134%	$1.27B	$1.37B	$696.80M 2025-03-31	$1.65B 2025-09-30	$1.63B 2025-12-31

Cost of Goods Sold (COGS)	73.72%	51.61%	$2.76B	$2.73B	$2.22B 2025-03-31	$3.37B 2025-12-31	$3.37B 2025-12-31

Income Statement

Balance Sheet

Cash Flow

Metrics

KPIs

% Change

Colors

#'s in thousands USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31 Get more features by creating a free Stock Unlock account: 2 portfolios, 5 positions per portfolio 2 watchlists, up to 10 tickers per watchlist More screener searches See full feature list	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
Total Revenue	19,292,000	17,600,800	15,557,700	12,728,500	42,069,000	8186043	2347104	6578906	4779987	1142385	4159025	7477362	6586734	6409774	7279143	8907568	6748818	435687
Cost of Goods Sold (COGS)	3,372,000	3,008,300	2,447,800	2,224,200	42,069,000	5206538	8348488	3212056	2151023	5302693	2321966	5084935	6113210	279818	1509243	2521690	9816306	5134175
Gross Profit	15,920,000	14,592,500	13,109,900	10,504,300	42,069,000	5955709	4847046	4615400	1078166	9615390	8387869	3369459	733907	7246523	9067968	7819183	4867947	6875813
Operating Expenses	6,934,000	6,206,400	6,089,100	5,202,500	42,069,000	2150678	930428	4549593	1981529	7465562	9237430	6993913	5806438	6056394	1199344	2437991	559995	6547918
Research & Development	3,802,000	3,465,700	3,336,100	2,733,700	42,069,000	1987241	2706703	2087445	9650247	1072834	9710915	9011147	1864579	8956203	8071826	9485435	2153967	7870405
Selling, General & Administrative Expenses	3,132,000	2,740,700	2,753,000	2,468,800	42,069,000	1647739	7810995	1794430	5935005	2900861	3345714	808544	5701797	6759078	95138	1275531	6522202	5094883
Operating Income or Loss	8,986,000	8,386,100	7,020,800	5,301,800	42,069,000	1544942	1146328	176254	7900761	6437858	4585456	552126	5072841	211411	6848597	3274882	6957631	1152562
Interest Expense	--	-179,600	-249,000	-243,700	-224,700	9150610	6865071	9104708	1522760	8854661	9637643	1598038	2403792	328231	7682386	3291812	796914	8201320
Net Interest Income Expense	-123,000	-67,700	-95,000	-342,100	42,069,000	9710509	4316424	9777317	468698	4750829	2257385	5666918	4093815	2564598	5289770	957700	3983662	2315934
Non-Recurring Items	-613,000	-1,020,600	-153,800	-1,606,700	42,069,000	3512054	42781	9407578	9882547	2954242	3594833	9773576	6767504	9844754	3092969	7330962	4834199	6715109
Total Other Income/Expense Net	15,000	-65,400	4,400	103,100	42,069,000	5667715	3640972	2705205	8095791	4889829	4094900	6934002	5344882	4859384	2963239	6027535	8009359	836003
Income Before Tax	8,265,000	7,232,400	6,776,400	3,456,100	42,069,000	8054244	6951498	7059150	3943852	8746424	7689200	647471	2357596	7490784	4646511	8406924	4646442	4439053
Income Tax Expense	1,629,000	1,649,900	1,115,900	696,800	42,069,000	261187	7539348	4654962	541616	9112080	1324600	1874402	9880429	7001030	1183990	8862883	5737963	1682912
Earnings	6,636,000	5,582,500	5,660,500	2,759,300	42,069,000	5958345	9133498	5402520	8329084	4834071	4698812	1369226	9396560	7965864	5870546	1751262	5716644	3951486
Adjusted Net Income	6,023,000	4,561,900	5,506,700	1,152,600	42,069,000	9730213	9551304	2919926	114042	1564404	4539002	7667027	7630100	8809285	9398371	1109125	3726866	7020453
Net Income After Taxes	6,636,000	5,582,500	5,660,500	2,759,300	42,069,000	7435392	6159965	2396177	7408840	9824715	1795682	1238693	6142714	1372317	7509562	8450337	667753	3864097
Diluted Shares Outstanding	898,002	898,800	899,800	900,600	42,069	4095990	6435773	5656691	247690	135082	3606429	8088232	8172803	7556397	8028723	3148663	5248850	3569025
Diluted EPS	7.39	6.21	6.29	3.06	42,069	3880555	4793810	925168	1589725	2651032	6233555	718994	3781714	6529917	5466423	2635678	1603524	235016
Adjusted EPS	6.71	5.08	6.12	1.28	42,069	9391118	4097051	2727854	9442282	3151508	5994196	1437728	4272696	5841504	4792628	9690578	6042532	2287674
EBITDA	9,571,700	8,856,100	7,499,300	5,764,600	42,069,000	8338766	6957986	6537577	9199041	2745451	1996268	1012515	4356741	3390309	4675890	9206584	6767498	7957579